Address: Kharkiv, 61022, Trynklera st., 6

 E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Ag. Director of the Research Institute of Experimental and Clinical Medicine – Anton Tkachenko, MD, MSc, PhD

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Ag. Deputy Director of the Research Institute of Experimental and Clinical Medicine – Anatolii Onishchenko, MD, PhD

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Structure of the Research Institute of Experimental and Clinical Medicine:

- Administration (Director and Deputy Director);

- Laboratory of Cellular Technologies;

- Laboratory of Molecular and Cellular Pathology;

- Laboratory of Immunological, Molecular and Biological Research.

Research Institute of Experimental and Clinical Medicine aims at improving the quality of research, providing innovative research technologies, performing research in the fields of fundamental and clinical medicine, developing and implementing novel medical approaches for diagnosis, prevention and treatment of diseases at Kharkiv National Medical University.

Specialization of the Research Institute of Experimental and Clinical Medicine.

Fundamental and applied research is performed in the fields of:

- Molecular and genetic, as well as cellular basics of disease pathogenesis;

- Development of novel preventive, diagnostic and treatment approaches, technologies;

- Quantitative and functional assessment of cellular populations (immunophenotyping) to characterize immunological aspects of various diseases;

- Elucidation of regulatory mechanisms in the immune system;

- Features of post-receptor cytokine signaling in the immune cells in various diseases;

-Peculiarities of the redox state of cells under the influence of different factors and in various diseases;

- Signaling pathways in cell death (apoptosis, necrosis, necroptosis, autophagy, pyroptosis, netosis, etc) and features of cell death in infections and non-communicable diseases;

- Features of cell membrane phospholipid bilayers in pathological conditions;

- Evaluation of the therapeutic potential of stem cells;

- Assessment of the effectiveness and biosafety of diverse nanoparticles as therapeutic agents;

- Evaluation of the mechanisms for toxic effects of food additives and other xenobiotics on cells.